New Drug Could Help Maintain Weight Loss After Ozempic and Wegovy

New Drug Could Help Maintain Weight Loss After Ozempic and Wegovy

A new clinical trial is exploring a different strategy for tackling one of obesity treatment’s biggest challenges: keeping weight off after initial success. GLP-1 drugs such as Ozempic and Wegovy have reshaped how obesity is treated, but many patients struggle to maintain weight loss after stopping these medications. A new clinical trial led by George [...]

The GLP-1 Cliff: What Science Actually Shows When Patients Stop Taking Ozempic and Wegovy

They call it the rebound. Patients who stop taking GLP-1 receptor agonists like semaglutide — sold under the brand names Ozempic and Wegovy — regain a substantial portion of their lost weight within a year. That much has been known for a while. But a growing body of research is now filling in the details of what happens across nearly every system in the body when these drugs are discontinued, and the picture is more complicated than a simple num…